ResearchMoz

Liver Cancer Market

List of reports from Liver Cancer

Displaying 1 to 20 (of 20 records)
Metastatic Liver Cancer - Pipeline Review, H2 2014
Jul 2014   |   By - Global Markets Direct
Metastatic Liver Cancer - Pipeline Review, H2 2014 Summary Global Markets Directs, Metastatic Liver Cancer - Pipeline Review, H2 2014, provides an overview of the Metastatic Liver Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Liver Cancer, complete with comparative analysis at various stages, therapeutics assessment...
$2000
Liver Cancer Treatment Drugs Markets in China
Jun 2014   |   By - Asia Market Information & Development Company
China's demand for Liver Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003,...
$4000
Metastatic Liver Cancer - Pipeline Review, H1 2014
Feb 2014   |   By - Global Markets Direct
Metastatic Liver Cancer - Pipeline Review, H1 2014 Summary Global Markets Directs, Metastatic Liver Cancer - Pipeline Review, H1 2014, provides an overview of the Metastatic Liver Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Liver Cancer, complete with comparative analysis at various stages, therapeutics assessment...
$2000
Metastatic Liver Cancer Global Clinical Trials Review, H2, 2013
Dec 2013   |   By - GlobalData
Metastatic Liver Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, Metastatic Liver Cancer Global Clinical Trials Review, H2, 2013" provides data on the Metastatic Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Liver Cancer. It includes an overview of the trial...
$2500
Liver Cancer Global Clinical Trials Review, H2, 2013
Nov 2013   |   By - GlobalData
GlobalData's clinical trial report, Liver Cancer Global Clinical Trials Review, H2, 2013" provides data on the Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook...
$2500
Liver Cancer - Pipeline Review, H2 2013
Jul 2013   |   By - Global Markets Direct
Global Markets Directs, Liver Cancer - Pipeline Review, H2 2013, provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Liver Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Liver Cancer....
$2000
Metastatic Liver Cancer - Pipeline Review, H2 2013
Jul 2013   |   By - Global Markets Direct
Global Markets Directs, Metastatic Liver Cancer Pipeline Review, H2 2013, provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Liver Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development...
$2000
Liver Cancer Partnering 2007-2013
Jul 2013   |   By - Current Partnering
The Liver Cancer Partnering 2007-2013 provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of liver cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the...
$995
Liver Cancer - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Global Markets Directs, 'Liver Cancer - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Liver Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Liver...
$2000
Metastatic Liver Cancer - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Global Markets Directs, 'Metastatic Liver Cancer Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Liver Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development...
$2000
Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail
Dec 2012   |   By - GBI Research
Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail Summary Leading business intelligence provider, GBI Research, has released its latest research report, entitled: “Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted...
$3500
Liver Cancer Global Clinical Trials Review, H2, 2012
Dec 2012   |   By - GlobalData
Liver Cancer Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, Liver Cancer Global Clinical Trials Review, H2, 2012" provides data on the Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their...
$2500
Liver Cancer - Pipeline Review, H2 2012
Sep 2012   |   By - Global Markets Direct
Liver Cancer Pipeline Review, H2 2012 Global Markets Directs, 'Liver Cancer Pipeline Review, Global Markets Directs, 'Liver Cancer Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Liver Cancer, complete with latest updates, and special features on late-stage and...
$2500
Chinese Markets for Liver Cancer Treatment Drugs
Aug 2012   |   By - Asia Market Information & Development Company
China's demand for liver cancer treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data...
$4000
Liver Cancer Partnering 2007-2012
Jun 2012   |   By - Current Partnering
The Liver Cancer Partnering 2007-2012 provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of liver cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the...
$995
Liver Cancer Partnering Partnering 2007-2012
Mar 2012   |   By - Current Partnering
This is an on demand report, it will take 20 to 25 working days to complete The ‘Liver Cancer Partnering 2007-2012’ provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of liver cancer partnering deals. The majority of deals are...
$995
Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012
Jan 2012   |   By - GlobalData
  GlobalData's clinical trial report, Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial...
$1000
Liver Cancer Global Clinical Trials Review, H2, 2011
Nov 2011   |   By - GlobalData
Liver Cancer Global Clinical Trials Review, H2, 2011 GlobalData's clinical trial report, Liver Cancer Global Clinical Trials Review, H2, 2011" provides data on the Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their recruitment status as...
$1000
Liver Cancer Global Clinical Trials Review, Q4, 2010
Dec 2010   |   By - GlobalData
GlobalData's clinical trial report, “ Liver Cancer Global Clinical Trials Review, Q4, 2010"" provides data on the Liver Cancer clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world,...
$1000
Metastatic Liver Cancer Global Clinical Trials Review, Q4, 2010
Dec 2010   |   By - GlobalData
GlobalData's clinical trial report, “Metastatic Liver Cancer Global Clinical Trials Review, Q4, 2010"" provides data on the Metastatic Liver Cancer clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Metastatic Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial...
$1000
 
Displaying 1 to 20 (of 20 records)

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData

Popular Categories

 

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us

Upcoming Reports